Skip to main content
Article thumbnail
Location of Repository

Increasing Output and Low Publication Rate of Brazilian Studies Presented at the American Society of Clinical Oncology Annual Meetings

By Everardo D. Saad, Cecília M. A. Pinheiro, André L. S. Masson, Gustavo Borghesi, Paulo M. Hoff and Flavio E. Prisco
Topics: Editorial
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier: oai:pubmedcentral.nih.gov:2664242
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. Are abstracts presented at the EAU meeting followed by publication in peerreviewed journals? A critical analysis.
    2. (2004). Clinical research in Brazil. Ciência & Saúde Coletiva
    3. De Oliveira PL. The Brazilian investment in science and technology.
    4. Erlotinib in previously treated non-small-cell lung cancer.
    5. Fate of cardiology research originally published in abstract form.
    6. (2007). Full publication of results initially presented in abstracts. Cochrane Database Syst Rev.
    7. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
    8. Geography of clinical cancer research publications from 1995 to 1999. Eur
    9. Graduate education at the faculty of medicine of the University of Sao Paulo: quo vadis?
    10. (2006). Highlights from the 42nd annual meeting of the
    11. Impact factor, scientific production and quality of Brazilian medical journals. Mem Inst Oswaldo Cruz.
    12. (2008). Mapping cancer, cardiovascular and malaria research in Brazil.
    13. (2007). Ministério da Saúde. Datasus. Informações de saúde. Mortalidade - Brasil. Available at http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/ cnv/obtuf.def (Accessed
    14. (2007). Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2006: Incidência de Câncer no Brasil. Available at http://www.inca.gov.
    15. multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
    16. Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations.
    17. Publication rate of abstracts presented at the annual meeting of the American Urological Association.
    18. (2004). Publication rates of abstracts presented at annual scientific meetings: how does the Royal Australian and New Zealand College of Radiologists compare? Australas Radiol.
    19. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
    20. Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting.
    21. (1992). Tannock IF. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol.
    22. The modest but growing Brazilian presence in psychiatric, psychobiological and mental health research: assessment of the 1998-2002 period.
    23. The scientific production of Brazilian neurologists: 1995-2004. Arq Neuropsiquiatr.
    24. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.